CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Address concerns with India trade/IP policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN New | — |
| TODD E GILLENWATER | — |
Budget/Appropriations BUD
Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation; FDA Appropriations; PTO Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN New | — |
| TODD E GILLENWATER | — |
Immigration IMM
Support STEM-Ed/H-1B related provisions in any immigration reform measure.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN New | — |
| TODD E GILLENWATER | — |
Medical/Disease Research/Clinical Labs MED
Support NIH research funding. Support Viral Hepatitis Testing Act. Support reforms to reduce administrative & regulatory burdens on scientific productivity, innovation & collaboration. Support reforms to support & evolve the scientific workforce continuum.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN New | — |
| TODD E GILLENWATER | — |
Financial Institutions/Investments/Securities FIN
Address concerns re biomedical corporate mergers and acquisitions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN New | — |
| TODD E GILLENWATER | — |
Taxation/Internal Revenue Code TAX
Support repeal of medical device tax. Support extension of Therapeutic Discovery Tax Credit and R&D credit. Oppose repeal of Orphan Drug Tax Credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN New | — |
| TODD E GILLENWATER | — |
Copyright/Patent/Trademark CPT
Address concerns with provisions of patent litigation reform, including Covered Business Method patents.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN New | — |
| TODD E GILLENWATER | — |
Health Issues HCR
Support legislation increasing access to wireless technologies.FDA review process consistency and predictability. Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN New | — |
| TODD E GILLENWATER | — |
Medicare/Medicaid MMM
Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs, and 2015 Hospital Outpatient Prospective Payment System. Address concerns with Medicaid coverage of specialty drugs. Support creation of incentives for antibiotics development. Oppose changes to Medicare Advantage and Part D prescription drug benefit. Support Treat and Reduce Obesity Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN New | — |
| TODD E GILLENWATER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.